MedTrace Logo

The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism

NCT05994586 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-08-16

No results posted yet for this study

Summary

The aim of the study is to demonstrate that a daily supplementation of AP029 Mix: I) has a positive effect on reducing side effects of metformin, while enhancing the therapeutic effect of metformin; II) normalizes prediabetes biomarkers in order to prevent further progression into diabetes.

Conditions

Interventions

DIETARY_SUPPLEMENT

AP029 mix

Polyphenol-rich plant extracts Twice a day

OTHER

Placebo

Twice a day

Sponsors & Collaborators

  • AronPharma Sp. z o. o.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-25
Primary Completion
2023-11-26
Completion
2023-11-26

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05994586 on ClinicalTrials.gov